FutuRx
FutuRx is an Israel-based, privately held biotechnology accelerator founded in 2014 in Ness Ziona. It operates a small core team that supports early-stage biotech ventures under CEO Kinneret Savitsky and co-founder Daria Mochly-Rosen.
- Company typePrivate
- Founded2014
- HeadquartersNess Ziona, Israel
- Headcount1–10
- GTM typeB2B
- OfferingServices
What FutuRx does
FutuRx is a privately held Israeli biotechnology accelerator founded in 2014 and headquartered in Ness Ziona, Israel. It operates as an incubator-style vehicle for early-stage biotech ventures, with a small core team of 1-10 employees and leadership comprising CEO Kinneret Savitsky and co-founder Daria Mochly-Rosen.
The company's described function is to support and accelerate biotechnology startups, consistent with the accelerator model: sourcing projects, providing operational and scientific support, and guiding portfolio companies through early development. Co-founder Daria Mochly-Rosen's academic profile points to a science-led origination approach, while the CEO role indicates day-to-day operational management of the accelerator's programs and stakeholder relationships.
No products, services, pricing, revenue mechanics, customer segments, or go-to-market details are disclosed in the available input, and the company website (futurx.co.il) currently returns a cPanel default error page rather than operational content. As a result, the business model — how FutuRx monetizes (whether through sponsor capital, equity in portfolio companies, milestone payments, or grant funding) — cannot be specified from the supplied data and would require primary-source confirmation.
FutuRx firmographics
Firmographics- Name
- FutuRx
- Website
- https://futurx.co.il
- Company type
- Private
- Founded year
- 2014
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- FutuRx is an Israel-based, privately held biotechnology accelerator founded in 2014 in Ness Ziona. It operates a small core team that supports early-stage biotech ventures under CEO Kinneret Savitsky and co-founder Daria Mochly-Rosen.
- Ownership category
- akta.pro rank
FutuRx industry classification
Industry- Product category
- Biotechnology Accelerator
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Accelerators & Incubators (Investor-Operated) (FSANAAAM)
- akta.pro secondary industry
- Corporate Accelerators & Startup Programs (FSANAHAD)
Keywords
Where FutuRx is headquartered
LocationHeadquarters
- HQ city
- Ness Ziona
- HQ country
- Israel
- HQ region
- Middle East
Markets served
FutuRx business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D
FutuRx product offering
Product offeringCore offering
FutuRx is an Israeli biotechnology accelerator based in Ness Ziona that supports early-stage biotech and life sciences ventures. Operating with a small team (1-10 employees) since its founding in 2014, the program provides acceleration services to biotech startup founders developing therapeutic and life sciences innovations.
Differentiator
Problem solved
Functional benefit
Companies that use FutuRx
Customer profileIdeal customer profiles1 record
FutuRx technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
FutuRx partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights2 records
FutuRx competitors and assessment
Company assessmentDirect peers
- IndieBio: Biotech-focused startup accelerator running structured cohort programs with equity investment — directly comparable model and category focus to FutuRx.
Others
- OrbiMed: Healthcare-dedicated investment firm; comparable as a typical LP / co-investor in biotech accelerator cohorts and adjacent to FutuRx's likely investor base.
Regional players
- Nielsen Israel (IN-D) Bio program: Israeli innovation/accelerator ecosystem that overlaps geographically and thematically with FutuRx in sourcing Israeli science-based founders.
Emerging players
- M Ventures (biotech programs): CVC-backed biotech venturing arm running structured incubation-style investments; comparable corporate-backed biotech founder support.
Broad incumbents
- Y Combinator (Bio track): Largest general accelerator with a dedicated life-sciences/bio vertical; competes with FutuRx for early-stage biotech applicants globally.
- Techstars: Global accelerator network with healthcare/biotech programs; competes for biotech founders and offers more extensive mentor networks.
Market position
Strengths2 records
Weaknesses3 records
Competitive moat2 records
Key risks3 records
Key highlights4 records
Customer concentration
FutuRx social profiles
Digital presenceFutuRx financial estimates
Financial estimateRevenue estimate
Valuation estimate
FutuRx leadership team
Management profileNumber of profiles
Profiles2 records
FutuRx funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
FutuRx M&A and investment
M&A and investmentM&A
Investments11 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about FutuRx
What does FutuRx do?
FutuRx is an Israeli biotechnology accelerator based in Ness Ziona that supports early-stage biotech and life sciences ventures. Operating with a small team (1-10 employees) since its founding in 2014, the program provides acceleration services to biotech startup founders developing therapeutic and life sciences innovations.
When was FutuRx founded?
FutuRx was founded in 2014. It employs 1 to 10 people.
Where is FutuRx based?
FutuRx is headquartered in Ness Ziona, Israel, in the Middle East region.
Who are FutuRx's main competitors?
IndieBio is listed as a direct peer. OrbiMed is listed as an others. Nielsen Israel (IN-D) Bio program is listed as a regional player. M Ventures (biotech programs) is listed as an emerging player. Broad incumbents are Y Combinator (Bio track) and Techstars.
Does FutuRx have an API?
No public API is recorded for FutuRx.
What industry is FutuRx in?
FutuRx's product category is Biotechnology Accelerator. Its primary akta.pro industry code is FSANAAAM, Accelerators & Incubators (Investor-Operated), with a secondary code of FSANAHAD, Corporate Accelerators & Startup Programs. Its NAICS code is 541714 and its SIC code is 8731.